Tag: ESWI 2025
-
CSL Seqirus Highlights 14 Abstracts at ESWI 2025: Advancing Enhanced Seasonal Influenza Vaccines
CSL Seqirus to Present 14 Abstracts at ESWI 2025 CSL Seqirus, a global leader in influenza vaccines, announced it will present 14 abstracts at the European Scientific Working group on Influenza (ESWI) conference, taking place in Valencia from 20 to 23 October 2025. The presentations highlight the value of enhanced seasonal influenza vaccines and reinforce…
-
Enhanced Influenza Vaccines Take Spotlight at ESWI 2025
CSL Seqirus to Present 14 Abstracts at ESWI 2025 CSL Seqirus, a leading influenza vaccine provider, announced today that it will present 14 abstracts at the European Scientific Working group on Influenza (ESWI) conference, taking place from 20–23 October in Valencia, Spain. The company’s participation underscores the vital role of enhanced seasonal influenza vaccines in…
-
CSL Seqirus Highlights 14 ESWI Abstracts on Enhanced Seasonal Influenza Vaccines
CSL Seqirus to Present 14 Abstracts at ESWI 2025 CSL Seqirus, part of CSL (ASX: CSL), announced today that it will present 14 abstracts at the European Scientific Working group on Influenza (ESWI) conference, taking place October 20–23 in Valencia, Spain. The presentations underscore the value of enhanced seasonal influenza vaccines and reinforce their critical…